about
Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferasesNAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variantThe structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazidMolecular cloning, characterisation and ligand-bound structure of an azoreductase from Pseudomonas aeruginosaDivergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferaseStructure of HsaD, a steroid-degrading hydrolase, fromMycobacterium tuberculosisCharacterization of a Carbon-Carbon Hydrolase from Mycobacterium tuberculosis Involved in Cholesterol MetabolismRole of tyrosine 131 in the active site of paAzoR1, an azoreductase with specificity for the inflammatory bowel disease prodrug balsalazideA novel mechanism for azoreductionProbing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active siteCharacterization of an oxidoreductase from the arylamine N-acetyltransferase operon in Mycobacterium smegmatisPiperidinols That Show Anti-Tubercular Activity as Inhibitors of Arylamine N-Acetyltransferase: An Essential Enzyme for Mycobacterial Survival Inside MacrophagesActivation of nitrofurazone by azoreductases: multiple activities in one enzymeIdentification of NAD(P)H Quinone Oxidoreductase Activity in Azoreductases from P. aeruginosa: Azoreductases and NAD(P)H Quinone Oxidoreductases Belong to the Same FMN-Dependent Superfamily of EnzymesStructure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversityA gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophagesExpression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferaseA novel color change mechanism for breast cancer biomarker detection: naphthoquinones as specific ligands of human arylamine N-acetyltransferase 1From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathwayArylamine N-acetyltransferase 2 expression in the developing heartIdentification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tubercularsStructural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts.Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa.Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.Improvement of the expression and purification of Mycobacterium tuberculosis arylamine N-acetyltransferase (TBNAT) a potential target for novel anti-tubercular agents.The pharmacogenetics of NAT: structural aspects.Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.Homologues of xenobiotic metabolizing N-acetyltransferases in plant-associated fungi: Novel functions for an old enzyme family.Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism.Changes in consensus arylamine N-acetyltransferase gene nomenclature.Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system.Arylamine N-acetyltransferases.Arylamine N-acetyltransferases in mycobacteria.Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.Update on the pharmacogenetics of NATs: structural considerations.Arylamine N-acetyltransferases--from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention.Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolizing enzyme arylamine N-acetyltransferase type 2 in mice.Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1.
P50
Q24618939-7AFE9684-CA57-41D6-9FE9-DBCD9171873FQ24791908-20E9D670-8016-4C42-8555-B4DF941A1D7BQ27639119-FEF351C3-1BA2-4FAE-825C-B086DC0D0297Q27648671-F031500E-D4B1-4877-9D3D-F92B9087A3B8Q27649063-ADFEAF1B-F920-4C1E-B6EB-F4FDE5B4ED37Q27649383-B0ED3622-7E62-4FAB-BFCD-81C4F5DE5184Q27658021-6B4553D6-E720-4447-B639-9FD9A21BF18AQ27658886-3934A4B1-FB1D-4FE0-9F0D-D3D9E97029FDQ27660836-5DEB39C9-40AC-499E-80BD-7C1301415BA8Q27666450-8F42E817-B77A-4DAC-80C9-1DEA9A78A760Q27674748-E9D69DDF-5871-42FE-8446-9A3F64182CD2Q27675714-D7E77807-7E09-4F27-A075-27A8CED25E6EQ27677411-B476B0C6-D69C-4233-BBB8-C2E0727BBB95Q27684286-02052D96-18DD-463E-A1C0-2AFE792B900BQ27685295-F0DB1637-EA7C-4B57-9E32-2CB40399C3FCQ28486798-FAFA6D51-C7E7-49EF-9E7E-10B205B67D2EQ28493134-ABE95DB1-2356-4E2F-8905-FD8CD10F2F97Q28535117-CD694F81-488C-40D2-AC5B-59CB0E94DDB6Q28538748-88052247-2974-4EC1-9531-DBD220527FB8Q28585671-D7C6BDCD-A46A-45EF-B30A-B4864A2DA8CEQ28587286-2C98C8B6-C0F4-4F79-9A52-B775BA5ED982Q28833704-48716873-77C0-4E9B-B216-4C75450C92C1Q31163532-3A4A4EE3-84B6-425C-AAC1-ABF8270E14B0Q33279454-39F02137-92CC-4706-B0A9-A51E4279FFC6Q33758781-D61B867D-DB2F-4B52-83C6-2EA1B4DDF724Q33964624-465B3BFD-03C3-4A79-A89E-5DCEBE12727EQ34609118-2EBC8C21-E707-45D0-BCAE-0559C1D39BB4Q35458746-89C5E6CD-52D9-43CB-BD41-C531B2FBCE32Q35973985-6FA018CA-A475-4C6A-98FB-9453EDC670F9Q36393217-B46E5098-82A6-4F1B-8503-15B3E39B8C37Q36563059-DE73166B-ED94-4544-B2FA-2EE3A394F50CQ36662826-F4D8DB08-1462-4116-9D62-4A2B9837B827Q36726842-226B60C9-CBFC-4FC9-AF4C-DE3950267142Q36788399-0AD19E76-E92A-49BE-A7DB-B0A6351344D8Q37235382-587D0207-83F8-4874-9DCE-1D750C9CF4C3Q37292782-21EB5134-41BD-43F9-83D4-E81EB2DF026EQ37329162-80CE4E43-20FA-4AE7-9EF9-A84611436AD2Q38024912-C73ED24D-480A-4FB2-B150-D0188A0058F7Q38351718-1F174298-0C8B-4CD7-B925-DD1DFBCFD420Q39001734-219DF894-6754-4D22-80D5-6EE8A875DE7B
P50
name
Edith Sim
@en
type
label
Edith Sim
@en
prefLabel
Edith Sim
@en